The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 closed the day up more than a per cent (1.08%).

All sectors bar one finished in the green. Energy fell 1.5 per cent, but Healthcare lead gains, nearly two per cent (1.97%). Telecommunications followed, up 1.7 per cent.

In the green

Australian mineral sands producer, Base Resources (ASX:BSE) surged 124 per cent on a forged alliance with Energy Fuels, a leading uranium mining company in the United States.

Energy Fuels is set to acquire all issued shares of Base Resources under Australia’s Corporations Act.

This merger aims to advance the company into a global leadership position in the critical minerals sector, enhancing market capitalisation, liquidity, and funding.

BSE closed the day at 23.5 cents

Small cap, mineral exploration company, Lightning Minerals (ASX:L1M) gained 21.6 per cent after it finalised a definitive agreement to acquire Bengal Mining (Bengal).

Bengal will operate through its wholly owned subsidiary Tigre Mineracao, possessing option agreements for two lithium projects, Caraibas and Sidronio, located in Brazil’s renowned Lithium Valley district in Minas Gerais.

Field work is set to commence upon deal completion and approval.

L1M closed the day at 9 cents.

Recce Pharmaceuticals (ASX:RCE) is up nearly 7.5 per cent, upon posting its latest quarterly results.

The company ended March with $8.5M in cash, an increase of around 100% Quarter on Quarter.

RCE closed the day at 57 cents.

In the red

Galan Lithium (ASX:GLN) shares fell 13 per cent, despite the Catamarca Governor in Argentina signing a commercial agreement to support permit grants for the commercialisation of lithium chloride concentrate from the Hombre Muerto West lithium brine project (HMW).

The permits will allow for the domestic sale or export of lithium chloride concentrate;

Galan commits to pursuing further downstream processing routes after 4 years, in a location outside the Hombre Muerto salar.

GLN closed the day at 33.5 cents.

Biotech company PYC Therapeutics (ASX:PYC) fell more than a per cent, despite revealing its drug, PYC-003 – designed to address Polycystic Kidney Disease- has now progressed to human trials.

The drug has shown promising safety and tolerability profiles in preclinical studies.

PYC closed the day at 9 cents.

DroneShield (ASX:DRO) dropped 16 per cent after it announced a $100 million capital raise through a two-tranche placement.

The first tranche of $70 million is fully committed, while the second $30 million tranche awaits shareholder approval.

The investor response indicates an attitude of wariness following the news.

DRO closed the day at 94 cents.

More From The Market Online
The Market Online Video

ASX Market Close: Bourse finishes week on a high as Wisetech pummeled | November 22, 2024

The ASX200 closed up 0.85% at 8,393 points. Economists increasingly expect interest rates in Australia won’t…
The Market Online Video

HotCopper Highlights: Your most watched stocks for Week 47, 2024

In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing,…
Nuclear explosion mushroom cloud concept

Week 47 Wrap: HotCopper users’ most watched; Brent lifts on Putin’s scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in th…